The digitization of care has led to the creation of products and services available at the point of care that until now were the domain of large, clinical facilities with expensive capital equipment.
One company leading the charge has been Butterfly Network, the Guilford, Connecticut public company, that has created a handheld probe capable of doing full-body ultrasound either at the bedside or point-of-care. The Butterfly iQ+ is a prescription device and is meant to be used only by trained healthcare professionals.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
The company began with the really ambitious goal of hoping to replace ultrasound carts. While that may have collided with decades long practice and entrenched culture, this is one company that is still hoping to transform the practice of medicine. In this episode of Pivot, I speak with John Martin, chief medical officer of Butterfly Network, on the evolution of the company and its future goals.
